KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.
暂无分享,去创建一个
[1] D. Ganem,et al. Array-Based Transcript Profiling and Limiting-Dilution Reverse Transcription-PCR Analysis Identify Additional Latent Genes in Kaposi's Sarcoma-Associated Herpesvirus , 2010, Journal of Virology.
[2] Paul Kellam,et al. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. , 2010, Genes & development.
[3] D. Ganem,et al. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. , 2009, Cell host & microbe.
[4] Bryan R. Cullen,et al. In-Depth Analysis of Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Expression Provides Insights into the Mammalian MicroRNA-Processing Machinery , 2009, Journal of Virology.
[5] B. Chandran,et al. Kaposi's Sarcoma-Associated Herpesvirus Upregulates Angiogenin during Infection of Human Dermal Microvascular Endothelial Cells, Which Induces 45S rRNA Synthesis, Antiapoptosis, Cell Proliferation, Migration, and Angiogenesis , 2009, Journal of Virology.
[6] H. Erfle,et al. A Systems Biology Approach To Identify the Combination Effects of Human Herpesvirus 8 Genes on NF-κB Activation , 2009, Journal of Virology.
[7] T. Schulz,et al. Viral Inhibitor of Apoptosis vFLIP/K13 Protects Endothelial Cells against Superoxide-Induced Cell Death , 2008, Journal of Virology.
[8] C. Lebbé,et al. Kaposi sarcoma in transplantation. , 2008, Transplantation reviews.
[9] M. Lagunoff,et al. Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells , 2008, Journal of Virology.
[10] Ling Wang,et al. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. , 2008, Cancer research.
[11] C. Boshoff,et al. Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. , 2008, Molecular cell.
[12] D. Ganem,et al. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. , 2008, Virology.
[13] Young Bong Choi,et al. Autocrine and Paracrine Promotion of Cell Survival and Virus Replication by Human Herpesvirus 8 Chemokines , 2008, Journal of Virology.
[14] C. Rinaldo,et al. Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN , 2008, Journal of Virology.
[15] N. Field,et al. vFLIP from KSHV inhibits anoikis of primary endothelial cells , 2008, Journal of Cell Science.
[16] N. Wood,et al. Human Immunodeficiency Virus–Associated Kaposi Sarcoma as an Immune Reconstitution Inflammatory Syndrome: A Literature Review and Case Report , 2008 .
[17] Bryan R. Cullen,et al. A viral microRNA functions as an orthologue of cellular miR-155 , 2007, Nature.
[18] S. Munro,et al. The small G proteins of the Arf family and their regulators. , 2007, Annual review of cell and developmental biology.
[19] Alberto Riva,et al. Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155 , 2007, Journal of Virology.
[20] K. Alitalo,et al. Viral Oncogene–Induced DNA Damage Response Is Activated in Kaposi Sarcoma Tumorigenesis , 2007, PLoS pathogens.
[21] D. Ganem,et al. Host Transcript Accumulation during Lytic KSHV Infection Reveals Several Classes of Host Responses , 2007, PloS one.
[22] C. Lebbé,et al. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. , 2007, Journal of the National Cancer Institute.
[23] Alberto Riva,et al. Identification of Cellular Genes Targeted by KSHV-Encoded MicroRNAs , 2007, PLoS pathogens.
[24] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. , 2007, Cancer research.
[25] S. Rafii,et al. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. , 2007, Cancer cell.
[26] J. Zhao,et al. Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13 , 2007, Oncogene.
[27] M. Samols,et al. Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. , 2007, The Journal of infectious diseases.
[28] Ling Wang,et al. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. , 2007, Blood.
[29] Shou-Jiang Gao,et al. Kaposi's Sarcoma-Associated Herpesvirus Promotes Angiogenesis by Inducing Angiopoietin-2 Expression via AP-1 and Ets1 , 2007, Journal of Virology.
[30] T. Schulz,et al. Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus , 2006, Journal of Virology.
[31] C. Lebbé,et al. Sirolimus Conversion for Patients with Posttransplant Kaposi's Sarcoma , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] M. Skobe,et al. Activation of NF-κB by the Latent vFLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype , 2006, Journal of Virology.
[33] R. Sun,et al. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. , 2006, Virology.
[34] Adam Grundhoff,et al. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. , 2006, RNA.
[35] Ling Wang,et al. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. , 2006, Cancer research.
[36] B. Cullen,et al. Transcriptional Origin of Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs , 2006, Journal of Virology.
[37] K. Luger,et al. The Nucleosomal Surface as a Docking Station for Kaposi's Sarcoma Herpesvirus LANA , 2006, Science.
[38] Satoko Matsumura,et al. Transcripts Encoding K12, v-FLIP, v-Cyclin, and the MicroRNA Cluster of Kaposi's Sarcoma-Associated Herpesvirus Originate from a Common Promoter , 2005, Journal of Virology.
[39] T. Schulz,et al. Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 , 2005, Journal of Virology.
[40] F. Oppenheimer,et al. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma. , 2005, Transplantation proceedings.
[41] D. Aboulafia,et al. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. , 2005, AIDS patient care and STDs.
[42] Jae U. Jung,et al. Characterization of the Kaposi's Sarcoma-Associated Herpesvirus K1 Signalosome , 2005, Journal of Virology.
[43] J. Richardson,et al. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Thirlwell,et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] J. Nicholas. Review: Human Gammaherpesvirus Cytokines and Chemokine Receptors , 2005 .
[46] M. Samols,et al. Cloning and Identification of a MicroRNA Cluster within the Latency-Associated Region of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.
[47] Blossom Damania,et al. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Soulillou,et al. Immunosuppressive drugs and the risk of cancer after organ transplantation. , 2005, The New England journal of medicine.
[49] L. Gesualdo,et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. , 2005, The New England journal of medicine.
[50] C. Boshoff,et al. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. , 2005, Blood.
[51] C. Sander,et al. Identification of microRNAs of the herpesvirus family , 2005, Nature Methods.
[52] D. Ganem,et al. The Kaposin B Protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs , 2005, Science.
[53] D. Wolf,et al. KAPOSI'S SARCOMA–ASSOCIATED HERPESVIRUS: Clinical, Diagnostic, and Epidemiological Aspects , 2005, Critical reviews in clinical laboratory sciences.
[54] M. Kane,et al. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] Elizabeth Brazeau,et al. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. , 2004, Virology.
[56] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[57] J. Vieira,et al. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.
[58] Jay W. Shin,et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus , 2004, Nature Genetics.
[59] S. Henderson,et al. Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.
[60] P. Chaudhary,et al. Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP) , 2004 .
[61] N. Jones,et al. The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. , 2004, The Journal of general virology.
[62] C. Grose,et al. Wild-Type Kaposi's Sarcoma-Associated Herpesvirus Isolated from the Oropharynx of Immune-Competent Individuals Has Tropism for Cultured Oral Epithelial Cells , 2004, Journal of Virology.
[63] Ling Wang,et al. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. , 2004, Cancer research.
[64] E. Cesarman,et al. KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells , 2004, The Journal of experimental medicine.
[65] D. Ganem,et al. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.
[66] L. Dagna,et al. Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. , 2003, Reviews in clinical and experimental hematology.
[67] S. Howell,et al. KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.
[68] R. Sun,et al. NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.
[69] B. Gazzard,et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma , 2003, AIDS.
[70] D. Ganem,et al. Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.
[71] D. Dittmer. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. , 2003, Cancer research.
[72] Frederick Y. Wu,et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus latency , 2003, Nature Medicine.
[73] S. Rafii,et al. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. , 2003, Cancer cell.
[74] K. Kaye,et al. The Kaposi's Sarcoma-Associated Herpesvirus K12 Transcript from a Primary Effusion Lymphoma Contains Complex Repeat Elements, Is Spliced, and Initiates from a Novel Promoter , 2002, Journal of Virology.
[75] B. Gazzard,et al. Prospective Study of the Effects of Antiretroviral Therapy on Kaposi Sarcoma‐Associated Herpesvirus Infection in Patients With and Without Kaposi Sarcoma , 2002, Journal of acquired immune deficiency syndromes.
[76] Jianhong Hu,et al. Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.
[77] D. Dittmer,et al. Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR , 2002, Journal of Virology.
[78] Ren Sun,et al. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. , 2002, Virology.
[79] L. Kaplan,et al. AIDS malignancies in the era of highly active antiretroviral therapy. , 2002, Oncology.
[80] M. Eby,et al. The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.
[81] G. Hayward,et al. Patterns of Gene Expression and a Transactivation Function Exhibited by the vGCR (ORF74) Chemokine Receptor Protein of Kaposi's Sarcoma-Associated Herpesvirus , 2002, Journal of Virology.
[82] G. Barillari,et al. Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma , 2002, Clinical Microbiology Reviews.
[83] E. Robertson,et al. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. , 2001, Virology.
[84] Hong Li,et al. Human Herpesvirus 8 (HHV-8)-Encoded Cytokines Induce Expression of and Autocrine Signaling by Vascular Endothelial Growth Factor (VEGF) in HHV-8-Infected Primary-Effusion Lymphoma Cell Lines and Mediate VEGF-Independent Antiapoptotic Effects , 2001, Journal of Virology.
[85] Jianhong Hu,et al. DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[86] P. Monini,et al. Biology of Kaposi's sarcoma. , 2001, European journal of cancer.
[87] Frederick Y. Wu,et al. Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.
[88] T. Piolot,et al. Close but Distinct Regions of Human Herpesvirus 8 Latency-Associated Nuclear Antigen 1 Are Responsible for Nuclear Targeting and Binding to Human Mitotic Chromosomes , 2001, Journal of Virology.
[89] C. Atzler,et al. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. , 2001, Molecular cell.
[90] M. Ballestas,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA , 2001, Journal of Virology.
[91] M. Tremblay,et al. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. , 2001, Journal of human virology.
[92] B. Chandran,et al. Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.
[93] Paul Kellam,et al. Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays , 2001, Journal of Virology.
[94] P. Moore,et al. Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 , 2001, Journal of Virology.
[95] L. Chieco‐Bianchi,et al. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. , 2000, Journal of the National Cancer Institute. Monographs.
[96] A. Wald,et al. Mucosal shedding of human herpesvirus 8 in men. , 2000, The New England journal of medicine.
[97] C. Boshoff,et al. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells , 2000, Nature Medicine.
[98] J. Gutkind,et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.
[99] B. Chandran,et al. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. , 2000, The American journal of pathology.
[100] C. Buchrieser,et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. , 2000, Journal of the National Cancer Institute.
[101] S. Mori,et al. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. , 2000, Virology.
[102] M. Corbellino,et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.
[103] E. Cesarman,et al. Viral G Protein–Coupled Receptor and Kaposi's Sarcoma , 2000, The Journal of experimental medicine.
[104] S. Franceschi,et al. Classic Kaposi sarcoma , 2000, Cancer.
[105] G. Nabel,et al. p53 inhibition by the LANA protein of KSHV protects against cell death , 1999, Nature.
[106] M. Skobe,et al. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. , 1999, The Journal of investigative dermatology.
[107] E. Robertson,et al. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.
[108] L. Hood,et al. Modulation of the NF-κB pathway by virally encoded Death Effector Domains-containing proteins , 1999, Oncogene.
[109] P. Biberfeld,et al. The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors , 1999, The Journal of experimental medicine.
[110] T. Veikkola,et al. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. , 1999, Cancer research.
[111] T. Veikkola,et al. Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells* , 1999, The Journal of Biological Chemistry.
[112] C. Boshoff,et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. , 1999, The Journal of infectious diseases.
[113] Lijun Wu,et al. A Complex Translational Program Generates Multiple Novel Proteins from the Latently Expressed Kaposin (K12) Locus of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.
[114] A. Haase,et al. Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.
[115] E. Jaffe,et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.
[116] C. Boshoff,et al. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. , 1999, Virology.
[117] M. Ballestas,et al. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.
[118] E. van Marck,et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[119] A. Palestine,et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.
[120] P. Moore,et al. Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter , 1999, Journal of Virology.
[121] C. Boshoff,et al. Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex , 1999, The EMBO journal.
[122] M. Mildner,et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[123] N. Jones,et al. Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus , 1999 .
[124] P. Allavena,et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.
[125] J. Haas,et al. Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8 , 1998, Journal of Virology.
[126] A. Haase,et al. A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.
[127] K. Ozato,et al. Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor , 1998, Journal of Virology.
[128] J. Brady,et al. Identification of Kaposin (Open Reading Frame K12) as a Human Herpesvirus 8 (Kaposi’s Sarcoma-Associated Herpesvirus) Transforming Gene , 1998, Journal of Virology.
[129] C. Pellet,et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV‐related Kaposi's sarcoma , 1998, AIDS.
[130] Jeffrey N. Martin,et al. Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.
[131] E. Cesarman,et al. Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[132] B. Ensoli,et al. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. , 1998, Cytokine & growth factor reviews.
[133] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[134] N. Jones,et al. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins , 1997, Nature.
[135] I. Potouridou,et al. Koebner phenomenon in classic Kaposi's sarcoma. , 1997, Acta dermato-venereologica.
[136] C. Boshoff,et al. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway , 1997, Oncogene.
[137] C. Boshoff,et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.
[138] B. Haar,et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.
[139] D. Ganem,et al. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. , 1997, Virology.
[140] M. Goldsmith,et al. A Kaposi’s Sarcoma-associated Herpesvirus-encoded Cytokine Homolog (vIL-6) Activates Signaling through the Shared gp130 Receptor Subunit* , 1997, The Journal of Biological Chemistry.
[141] J. Harrington,et al. Repetitive strain injuries , 1997, The Lancet.
[142] F. Neipel,et al. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.
[143] L. Liotta,et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. , 1997, The New England journal of medicine.
[144] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[145] C. Wood,et al. Activation of HHV-8 by HIV-1 tat , 1997, The Lancet.
[146] G. Hayward,et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 , 1997, Nature Medicine.
[147] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[148] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[149] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[150] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[151] F. Langmark,et al. Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic. , 1996, British Journal of Cancer.
[152] W. Zhong,et al. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.
[153] P. Simmonds,et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.
[154] B. Dezube. Clinical presentation and natural history of AIDS--related Kaposi's sarcoma. , 1996, Hematology/oncology clinics of North America.
[155] R. Gallo,et al. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[156] D. Noonan,et al. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. , 1996, Research in virology.
[157] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[158] C. Boshoff,et al. Cyclin encoded by KS herpesvirus , 1996, Nature.
[159] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[160] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[161] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[162] N. Bendsøe,et al. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. , 1996, The American journal of pathology.
[163] R. Sun,et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. , 1996, The New England journal of medicine.
[164] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[165] D R Hoover,et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.
[166] E. Cesarman,et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.
[167] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.
[168] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[169] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[170] L. Montagnier,et al. Kaposi's sarcoma and new herpesvirus , 1995, The Lancet.
[171] C. Fisher,et al. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma , 1995, The Lancet.
[172] V. Calvez,et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma , 1995, The Lancet.
[173] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[174] P. French,et al. The Koebner phenomenon and AIDS‐related Kaposi's sarcoma , 1994, The British journal of dermatology.
[175] S. Franceschi,et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. , 1994, British Journal of Cancer.
[176] J. Regezi,et al. Oral Kaposi's sarcoma: a 10-year retrospective histopathologic study. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[177] J. Regezi,et al. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. , 1993, The American journal of pathology.
[178] V. Beral,et al. Kaposi's sarcoma in England and Wales before the AIDS epidemic. , 1992, British Journal of Cancer.
[179] V. Beral,et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.
[180] S. Nakamura,et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.
[181] S. Nakamura,et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. , 1988, Science.
[182] P. G. Prioleau,et al. Kaposi's sarcoma occurring in a dermatome previously involved by herpes zoster. , 1988, Journal of the American Academy of Dermatology.
[183] JohnJ. Brooks. KAPOSI'S SARCOMA: A REVERSIBLE HYPERPLASIA , 1986, The Lancet.
[184] G. Wood,et al. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. , 1985, The American journal of pathology.
[185] B. Safai. KAPOSI'S SARCOMA: A REVIEW OF THE CLASSICAL AND EPIDEMIC FORMS a , 1984 .
[186] P. Klemp,et al. Cutaneous blood flow during white dermographism in patients with atopic dermatitis. , 1982, The Journal of investigative dermatology.
[187] Baig Ar,et al. Sex-chromatin values in rat epithelium. , 1967 .
[188] Kaposi,et al. Idiopathisches multiples Pigmentsarkom der Haut , 1872, Archiv für Dermatologie und Syphilis.
[189] D. Ganem,et al. Tandem array–based expression screens identify host mRNA targets of virus-encoded microRNAs , 2009, Nature Genetics.
[190] L. Pantanowitz,et al. Diagnostic Pathology BioMed Central Review Histological variants of cutaneous Kaposi sarcoma , 2008 .
[191] A. Wald,et al. Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. , 2007, The Journal of infectious diseases.
[192] D. Ganem,et al. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.
[193] D. Ganem,et al. The biology of Kaposi's sarcoma. , 2001, Cancer treatment and research.
[194] J. Fallon,et al. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. , 2001, Blood.
[195] C. Boshoff,et al. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. , 2000, Blood.
[196] T. Schulz,et al. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. , 1999, Advances in cancer research.